Loading...
Loading...
Of the 14 tracked institutions holding JBIO, 6 have a 3-year clone track record — 6 of them beat the S&P. Average holder's clone alpha: +5.6pt. It's a gauge of who owns the name, not just how many.
Among the 14 tracked institutional investors we monitor, JBIO (JADE BIOSCIENCES INC) is held with a combined value of $536.53M across 24,786,704 shares. The largest holder is FMR LLC with a position worth $202.80M. 2 funds opened new positions in the most recent quarter. 7 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$536.53M
Total Shares Held
24,786,704
Institutional Holders
14
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $202.80M | 0.01% | +28.8% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | $81.57M | 0.71% | - |
| 3 | BlackRock, Inc. | $62.25M | 0.00% | +21.1% |
| 4 | STATE STREET CORP | $51.89M | 0.00% | +256.2% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.46M | 0.06% | New |
| 6 | VANGUARD GROUP INC | $32.34M | 0.00% | +21.4% |
| 7 | BAKER BROS. ADVISORS LP | $27.34M | 0.14% | -25.0% |
| 8 | CITADEL ADVISORS LLC | $20.65M | 0.01% | +577.3% |
| 9 | MILLENNIUM MANAGEMENT LLC | $6.99M | 0.00% | +96.5% |
| 10 | Point72 Asset Management, L.P. | $3.72M | 0.01% | -36.7% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of JBIO with a position worth $202.80M, representing 0.01% of their portfolio. In total, 14 institutional investors hold JBIO with a combined value of $536.53M.
In the most recent quarter, 2 funds opened a new position in JBIO. Additionally, 7 increased their holdings and 4 reduced their positions.
Institutional investors hold $536.53M worth of JBIO stock across 14 positions. The largest institutional holder is FMR LLC with $202.80M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For JBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their JBIO positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| 2026-08-14 |
SEC Schedule 13D (activist) and 13G (passive) filings for JBIO. Filed when an investor acquires 5%+ ownership.
Last Close
$14.12
2026-10-02
YTD
-0.3%
31% of 52-week range
